Jorge Cortes, director of the Georgia Cancer Center at Augusta University, was selected as the inaugural editor-in-chief of the newest addition to the Blood journals portfolio: Blood Global Hematology.
More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.
